PROPRANOLOL HYDROCHLORIDE | A070120 | SCHERING CORP SUB SCHERING PLOUGH CORP
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Verex Laboratories Inc. - Citizen Petition FDA-1985-P-0019 Verex Laboratories, Inc. filed this citizen petition under 21 CFR 10.30 and Section 314.2(c)(d) on March 20, 1985, requesting that the FDA Commissioner find an Abbreviated New Drug Application suitable for propranolol HCl 160 mg constant-release-rate tablets marketed as PROBLOK, a tablet formulation | Other | 2012-09-06 | Granted | — |
Citizen Petition from Flemington Pharmaceutical Corporation FDA-1992-P-0493 Flemington Pharmaceutical Corporation filed this citizen petition under section 505(j)(2)(c) of the Federal Food, Drug, and Cosmetic Act and 21 CFR 314.55(d) requesting permission to file an Abbreviated New Drug Application for effervescent propranolol hydrochloride tablets 40 mg, which differs from | Other | 2008-10-15 | Granted | Flemington Pharmaceutical Corporation |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.